Pharmacological Modulation of p53 Function in Cancer Therapy
Journal:
Current Signal Transduction Therapy
Volume:
3
Page:
183-194
Author(s):
Razmik Mirzayans and David Murray
Targeted Therapies in Head and Neck Cancer: Past, Present and Future
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
156-166
Author(s):
Alexander D. Rapidis, Jan B. Vermorken and Jean Bourhis
The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
217-227
Author(s):
Antonio Rossi, Emilio Bria, Paolo Maione, Giovanni Palazzolo, Marzia Falanga and Cesare Gridelli
Metal Allergens of Growing Significance: Epidemiology, Immunotoxicology, Strategies for Testing and Prevention
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
7
Page:
145-162
Author(s):
Giovanni Forte, Francesco Petrucci and Beatrice Bocca
Current Dendrimer Applications in Cancer Diagnosis and Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
8
Page:
1165-1179
Author(s):
Istvan J. Majoros, Christopher R. Williams and James R. Baker Jr.
Astatine Radiopharmaceuticals: Prospects and Problems
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
177-196
Author(s):
Ganesan Vaidyanathan and Michael R. Zalutsky
FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
342-348
Author(s):
D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi
Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
392-403
Author(s):
Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome
Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
431-445
Author(s):
K. Agelopoulos, H. Buerger and B. Brandt
Targeting SphK1 as a New Strategy against Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
662-673
Author(s):
Dai Shida, Kazuaki Takabe, Dmitri Kapitonov, Sheldon Milstien and Sarah Spiegel